NYSE$EHC

Encompass Health Corp · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Encompass Health's second quarter results were reported, showing a decrease in revenues due to decreased volumes, partially offset by favorable pricing. Patient volumes have substantially rebounded from the low point experienced in April.

Encompass Health reported a decrease in net operating revenues and adjusted earnings per share for the second quarter of 2020 compared to the second quarter of 2019. The company's patient volumes have substantially rebounded from the low point experienced in April.

  • Net operating revenues decreased by 5.4% compared to Q2 2019.
  • Adjusted earnings per share decreased by 71.3% compared to Q2 2019.
  • Cash flows provided by operating activities increased by 52.9% compared to Q2 2019.
  • Adjusted free cash flow increased by 18.3% compared to Q2 2019.

Headline financials

Total Revenue

$1.07B

Previous: $1.14B-5.4%
EPS (adj)

$0.31

Previous: $1.08-71.3%
Discharges

41.7K

Previous: 46.7K-10.7%
Net patient revenue per discharge

$19.4K

Previous: $18.2K+6.2%
Capital Expenditures

-$167M

Previous: -$156M-6.9%
Free Cash Flow

-$133M

Previous: -$64.6M-106.0%
Net Income

$33.5M

Previous: $91.2M-63.3%
Operating Income

-$191M

Previous: -$234M+18.3%
Gross Profit

$1.02B

Previous: $700K+146114.3%
Cash & Equivalents

$419M

Previous: $222M+89.0%
Total Assets

$6.5B

Previous: $5.81B+11.9%
Stock-Based Comp

$9.9M

Previous: $45.9M-78.4%

Revenue & EPS history

Encompass Health · Revenue · Quarterly

$1.07B

Q2 2020-5.4%vs Q2 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Forward guidance

Forward-looking statements involve estimates based upon current information and risks that could cause actual results to differ materially. The company undertakes no duty to update forward-looking information.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+1.2%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.5%

Avg return

30 days after

64%

42 / 66 earnings

Positive

+11.8%

Q1 2025

Best reaction

-9.0%

Q1 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%+5.0%+6.0%
Q4 2025+5.9%+13.9%+7.4%
Q3 2025-6.9%-6.8%-7.5%
Q1 2025+11.8%+15.4%+17.2%
Q4 2024+1.3%-0.6%+0.7%
Q3 2024+7.0%+5.8%+10.0%
Q2 2024-8.7%-7.5%+1.0%
Q1 2024+0.3%+1.4%+2.5%
Q4 2023+1.7%+1.9%+5.9%
Q3 2023-1.9%+0.9%+6.7%
Q2 2023+5.0%+6.4%+7.6%
Q1 2023+0.7%-0.6%-5.9%
Q4 2022+1.6%+3.1%-9.1%
Q3 2022+6.4%+11.1%+16.6%
Q2 2022+0.6%+4.5%-4.0%
Q1 2022+2.6%+2.5%-2.0%
Q4 2021+1.5%-2.9%+8.8%
Q3 2021-6.0%-5.8%-9.8%
Q2 2021+0.7%+3.5%-4.1%
Q1 2021-1.6%-2.7%-2.5%
Q4 2020-3.9%-6.2%-6.1%
Q3 2020-2.6%-3.0%+25.9%
Q2 2020+4.5%+3.1%-6.4%
Q1 2020-1.1%-7.1%+6.4%
Q4 2019+0.4%+3.1%-2.6%
Q3 2019-5.8%+2.0%+5.5%
Q2 2019-4.0%-7.4%-12.6%
Q1 2019+5.3%+3.6%-4.6%
Q4 2018-4.4%-3.5%-13.3%
Q3 2018-5.7%-4.0%+1.4%
Q2 2018+8.8%+5.9%+17.4%
Q1 2018+7.2%+7.3%+10.3%
Q4 2017+3.0%+3.9%+7.7%
Q3 2017+1.8%+2.0%+8.7%
Q2 2017+1.9%-0.2%+3.6%
Q1 2017+7.9%+10.0%+6.3%
Q4 2016+0.1%+0.5%-1.9%
Q3 2016+1.8%+0.7%+5.6%
Q2 2016+6.7%+3.1%-0.3%
Q1 2016+10.9%
Q4 2015+9.2%
Q3 2015-0.3%
Q2 2015-2.9%
Q1 2015-9.0%
Q4 2014-4.7%
Q3 2014-3.0%
Q2 2014+7.4%
Q1 2014-0.4%
Q4 2013-2.8%
Q3 2013+0.6%
Q2 2013+4.7%
Q1 2013+3.1%
Q4 2012+7.2%
Q3 2012+2.5%
Q2 2012-3.7%
Q1 2012+9.2%
Q4 2010+3.9%
Q4 2011+3.9%
Q3 2011-1.0%
Q2 2011-9.0%
Q1 2010+0.4%
Q1 2011+2.5%
Q4 2008+7.8%
Q3 2010+2.2%
Q2 2010-1.0%
Q4 2009-1.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro